Notable Labs Ltd
NASDAQ:NTBL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heineken NV
SWB:HNK1
|
NL |
|
Polski Koncern Naftowy Orlen SA
OTC:PSKOF
|
PL |
|
Z
|
Zhejiang Taifu Pump Co Ltd
SZSE:300992
|
CN |
|
S
|
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
|
CN |
|
F
|
Flowers Foods Inc
F:FWF
|
US |
|
H
|
Hitevision Co Ltd
SZSE:002955
|
CN |
Notable Labs Ltd
Depreciation & Amortization
Notable Labs Ltd
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Notable Labs Ltd
NASDAQ:NTBL
|
Depreciation & Amortization
$384k
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Depreciation & Amortization
$14.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
25%
|
CAGR 10-Years
17%
|
|
|
Enlivex Therapeutics Ltd
NASDAQ:ENLV
|
Depreciation & Amortization
$292k
|
CAGR 3-Years
-26%
|
CAGR 5-Years
2%
|
CAGR 10-Years
31%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Depreciation & Amortization
$307k
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Depreciation & Amortization
$34k
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Pluri Inc
NASDAQ:PLUR
|
Depreciation & Amortization
$442k
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-14%
|
|
Notable Labs Ltd
Glance View
Notable Labs Ltd is a IL-based company operating in Biotechnology industry. Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The firm has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The firm's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
See Also
What is Notable Labs Ltd's Depreciation & Amortization?
Depreciation & Amortization
384k
USD
Based on the financial report for Jun 30, 2024, Notable Labs Ltd's Depreciation & Amortization amounts to 384k USD.
What is Notable Labs Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-24%
Over the last year, the Depreciation & Amortization growth was 7%. The average annual Depreciation & Amortization growth rates for Notable Labs Ltd have been -26% over the past three years , -24% over the past five years .
